Diagnostic accuracy of MRI-based radiomic features for EGFR mutation status in non-small cell lung cancer patients with brain metastases: a meta-analysis

ObjectiveThis meta-analysis aims to evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) based radiomic features for predicting epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients with brain metastases.MethodsWe systematically search...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuqin Long, Rong Zhao, Xianfeng Du
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1428929/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850086156877692928
author Yuqin Long
Rong Zhao
Xianfeng Du
author_facet Yuqin Long
Rong Zhao
Xianfeng Du
author_sort Yuqin Long
collection DOAJ
description ObjectiveThis meta-analysis aims to evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) based radiomic features for predicting epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients with brain metastases.MethodsWe systematically searched PubMed, Embase, Cochrane Library, Web of Science, Scopus, Wanfang, and China National Knowledge Infrastructure (CNKI) for studies published up to April 30, 2024. We included those studies that utilized MRI-based radiomic features to detect EGFR mutations in NSCLC patients with brain metastases. Sensitivity, specificity, positive and negative likelihood ratios (PLR, NLR), and area under the curve (AUC) were calculated to evaluate the accuracy. Quality assessment was performed using the quality assessment of prognostic accuracy studies 2 (QUADAS-2) tool. Meta-analysis was conducted using random-effects models.ResultsA total of 13 studies involving 2,348 patients were included. The pooled sensitivity and specificity of MRI-based radiomic features for detecting EGFR mutations were 0.86 (95% CI: 0.74-0.93) and 0.83 (95% CI: 0.72-0.91), respectively. The PLR and NLR were calculated as 5.14 (3.09, 8.55) and 0.17 (0.10, 0.31), respectively. Substantial heterogeneity was observed, with I² values exceeding 50% for all parameters. The AUC for the receiver operating characteristic analysis was 0.91 (95% CI: 0.88-0.93). Subgroup analysis indicated that deep learning models and studies conducted in Asian showed higher diagnostic accuracy compared to their respective counterparts.ConclusionsMRI-based radiomic features demonstrate a high potential for accurately detecting EGFR mutations in NSCLC patients with brain metastases, particularly when advanced deep learning techniques were employed. However, the variability in diagnostic performance across different studies underscores the need for standardized radiomic protocols to enhance reproducibility and clinical utility.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42024544131.
format Article
id doaj-art-ededc7d2bade43a382fcf76feffe0966
institution DOAJ
issn 2234-943X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-ededc7d2bade43a382fcf76feffe09662025-08-20T02:43:33ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-01-011410.3389/fonc.2024.14289291428929Diagnostic accuracy of MRI-based radiomic features for EGFR mutation status in non-small cell lung cancer patients with brain metastases: a meta-analysisYuqin Long0Rong Zhao1Xianfeng Du2Department of Respiratory and Critical Care Medicine, The Affiliated Dazu’s Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Radiology, The Affiliated Dazu’s Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Oncology, The Affiliated Dazu’s Hospital of Chongqing Medical University, Chongqing, ChinaObjectiveThis meta-analysis aims to evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) based radiomic features for predicting epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients with brain metastases.MethodsWe systematically searched PubMed, Embase, Cochrane Library, Web of Science, Scopus, Wanfang, and China National Knowledge Infrastructure (CNKI) for studies published up to April 30, 2024. We included those studies that utilized MRI-based radiomic features to detect EGFR mutations in NSCLC patients with brain metastases. Sensitivity, specificity, positive and negative likelihood ratios (PLR, NLR), and area under the curve (AUC) were calculated to evaluate the accuracy. Quality assessment was performed using the quality assessment of prognostic accuracy studies 2 (QUADAS-2) tool. Meta-analysis was conducted using random-effects models.ResultsA total of 13 studies involving 2,348 patients were included. The pooled sensitivity and specificity of MRI-based radiomic features for detecting EGFR mutations were 0.86 (95% CI: 0.74-0.93) and 0.83 (95% CI: 0.72-0.91), respectively. The PLR and NLR were calculated as 5.14 (3.09, 8.55) and 0.17 (0.10, 0.31), respectively. Substantial heterogeneity was observed, with I² values exceeding 50% for all parameters. The AUC for the receiver operating characteristic analysis was 0.91 (95% CI: 0.88-0.93). Subgroup analysis indicated that deep learning models and studies conducted in Asian showed higher diagnostic accuracy compared to their respective counterparts.ConclusionsMRI-based radiomic features demonstrate a high potential for accurately detecting EGFR mutations in NSCLC patients with brain metastases, particularly when advanced deep learning techniques were employed. However, the variability in diagnostic performance across different studies underscores the need for standardized radiomic protocols to enhance reproducibility and clinical utility.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42024544131.https://www.frontiersin.org/articles/10.3389/fonc.2024.1428929/fullMRIradiomicsnon-small cell lung cancerbrain metastasesEGFR mutations
spellingShingle Yuqin Long
Rong Zhao
Xianfeng Du
Diagnostic accuracy of MRI-based radiomic features for EGFR mutation status in non-small cell lung cancer patients with brain metastases: a meta-analysis
Frontiers in Oncology
MRI
radiomics
non-small cell lung cancer
brain metastases
EGFR mutations
title Diagnostic accuracy of MRI-based radiomic features for EGFR mutation status in non-small cell lung cancer patients with brain metastases: a meta-analysis
title_full Diagnostic accuracy of MRI-based radiomic features for EGFR mutation status in non-small cell lung cancer patients with brain metastases: a meta-analysis
title_fullStr Diagnostic accuracy of MRI-based radiomic features for EGFR mutation status in non-small cell lung cancer patients with brain metastases: a meta-analysis
title_full_unstemmed Diagnostic accuracy of MRI-based radiomic features for EGFR mutation status in non-small cell lung cancer patients with brain metastases: a meta-analysis
title_short Diagnostic accuracy of MRI-based radiomic features for EGFR mutation status in non-small cell lung cancer patients with brain metastases: a meta-analysis
title_sort diagnostic accuracy of mri based radiomic features for egfr mutation status in non small cell lung cancer patients with brain metastases a meta analysis
topic MRI
radiomics
non-small cell lung cancer
brain metastases
EGFR mutations
url https://www.frontiersin.org/articles/10.3389/fonc.2024.1428929/full
work_keys_str_mv AT yuqinlong diagnosticaccuracyofmribasedradiomicfeaturesforegfrmutationstatusinnonsmallcelllungcancerpatientswithbrainmetastasesametaanalysis
AT rongzhao diagnosticaccuracyofmribasedradiomicfeaturesforegfrmutationstatusinnonsmallcelllungcancerpatientswithbrainmetastasesametaanalysis
AT xianfengdu diagnosticaccuracyofmribasedradiomicfeaturesforegfrmutationstatusinnonsmallcelllungcancerpatientswithbrainmetastasesametaanalysis